Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Treatments for Eating Disorders

10.11.2004


Clinical eating disorders have one of the highest mortalities of any psychiatric ca tegory. They can be long lasting and life blighting. However, too often they are thought of by the general public, and sometimes even by health care professionals, either as trivial and perhaps glamorous or as rare and extraordinary.



A team of Leicester researchers is keen to correct these misconceptions and to portray eating disorders as important, serious, ordinary - and treatable. Getting better and escaping from an eating disorder is a demanding and active business but if sufferers can apply resolve and determination, modern treatments can provide reliable ladders that they use to climb back to health and a life worth living.

The researchers, based in the University of Leicester Department of Health Sciences (Division of Psychiatry), are conducting a major randomised controlled trial of psychological treatment for eating disorders, one of the largest ever trials of any psychological treatment.


Psychiatrist Dr Bob Palmer, a senior lecturer at the University, and his colleagues are comparing two new versions of cognitive behavioural therapy (CBT). The work, funded by a programme grant from the Wellcome Trust, is a joint project with the Department of Psychiatry at Oxford University, where the treatments have been developed by Professor Christopher Fairburn and Dr Zafra Cooper.

This two-centre study breaks new ground in a number of ways. Firstly, the treatments are novel and promise to be more effective than standard treatments.

Secondly, the recruitment of patients is aimed to be as wide and unselective as possible so as to avoid the criticism that research trials tend to select only ’special’ or ’easy’ patients. With few exceptions, if a patient referred to the Eating Disorders Service based at the Brandon Unit, run by Leicestershire Partnership NHS Trust, is confirmed as having an eating disorder, comes from a defined catchment area which the team calls ’Wellcomeshire’ and consents to take part, then they are in the trial.

And thirdly, the trial is the first to include not only people with anorexia nervosa (AN) and bulimia nervosa (BN) but also the many patients who present with severe eating disorders that do not precisely fit either diagnosis. These people are often described as having ’atypical’ disorders but the term is questionable since together they are numerous and not at all unusual. Furthermore, their disorders may be just as severe and serious as those that do neatly fit the full criteria. However, such cases have almost always been excluded from previous treatment research.

Dr Palmer explained: “People who suffer from either of the two main eating disorders - AN and BN - tend to worry to an unusual degree about weight, shape and eating. Ideas about weight and eating control seem to become tangled up with wider personal issues such as what they feel about themselves, what they think others think of them and so on. They usually try to control themselves and restrain their eating but the attempt at control itself gets out of control.

“The AN sufferer ‘succeeds’ but the control in eating restraint goes way too far and she finds herself at an abnormally low weight - sometimes dangerously so. The person with BN ’fails’ in her efforts at restraint and breaks out into binge eating and may then desperately try to compensate for this by inducing vomiting or taking large quantities of laxatives. People with ’atypical’ eating disorders usually share many of these features but have them in different combinations.”

The research being undertaken with Leicestershire Partnership NHS Trust aims to answer important questions about just how effective the newest treatments are and how they work. The project is more than half completed but it will be a couple more years before the results will be available.

Ather Mirza | alfa
Further information:
http://www.le.ac.uk

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>